Pulmonx (LUNG) Short-term Investments (2019 - 2025)

Pulmonx (LUNG) has reported Short-term Investments for 6 consecutive years, with $8.8 million the latest figure, recorded in Q2 2025.

• On a quarterly basis, Short-term Investments fell 82.85% year-over-year to $8.8 million in Q2 2025; TTM through Jun 2025 was $8.8 million, a 82.85% decrease from a year earlier, with the FY2024 full-year figure at $30.6 million, down 8.87% from the prior year.
• Short-term Investments was $8.8 million for Q2 2025 at Pulmonx, down from $14.1 million in the prior quarter.
• Over five years, Short-term Investments peaked at $51.1 million in Q2 2024 and troughed at $8.8 million in Q2 2025.
• A 5-year average of $30.8 million and a median of $33.6 million in 2023 frame the typical range for Short-term Investments.
• Across the five-year window, Short-term Investments jumped 318.17% in 2022 and slumped 82.85% in 2025, its largest moves.
• Over 5 years, Short-term Investments stood at $31.6 million in 2021, then gained by 24.84% to $39.4 million in 2022, then dropped by 14.84% to $33.6 million in 2023, then decreased by 8.87% to $30.6 million in 2024, then tumbled by 71.35% to $8.8 million in 2025.
• The last three Short-term Investments figures came in at $8.8 million (Q2 2025), $14.1 million (Q1 2025), and $30.6 million (Q4 2024), per Business Quant data.